In fact, both IGF-IR and DDR1 are overexpressed in various malignancies, and may sustain epithelial-to-mesenchymal transition, invasion, metastases, as well as cancer resistance to therapies [4–9, 24, 25]. Here, DDR1 is linked to cancer.